With Renesas IP deal, shareholders have the perfect guinea pig for measuring future potential value.
Renesas product range and it’s use applications for Akida are wide and substantial enough to be a significant marker for assessing BRNs commercial validity.
Note also that as future customers adapt their products to include Akida in their design the commercial value will only increase. Add the careful customer selectivity BRN management are adopting in its early stages of commercialisation.
There’s is no better future earnings predictor than the earnings produced through the Renasas IP deal.
Announcements don’t make share prices go up. Earnings growth and beating earnings expectations makes prices go up.
The word will eventually get out when Akida and its IP are being used across all Smart Sectors, and gaining traction commercially.
IMO DYOR
2020 BRN Discussion, page-26918
-
- There are more pages in this discussion • 2,396 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BRN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $375.8M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.5¢ | 19.8¢ | $726.6K | 3.597M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 76 | 1375679 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 482166 | 16 |
View Market Depth
| Last trade - 13.00pm 15/07/2024 (20 minute delay) ? |
| BRN (ASX) Chart |